Home Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say
 

Keywords :   


Biz Break: Pharmacyclics to sell in biggest biotech deal of the year, reports say

2015-03-05 00:53:04| Biotech - Topix.net

Today: Johnson & Johnson plans to buy Sunnyvale drugmaker Pharmacyclics for more than the $17 billion, according to the Financial Times. In a year that has already seen several blockbuster biotechnology deals, Sunnyvale drugmaker Pharmacyclics is set to be the biggest purchase so far, according to recent reports.

Tags: year say sell reports

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »